Gsk (GSK) Research & Development (2009 - 2026)
Gsk (GSK) posted Research & Development of $4.65 billion for the quarter ended Jun 30, 2026.
Gsk (GSK) Research & Development (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Gsk was $24.69 billion; for the year ended Dec 31, 2025, it was $9.92 billion, up 21.3% from the prior year.
- Annual Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 10.0% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Research & Development was $8.18 billion in the year ended Dec 31, 2024 (+5.7%), $7.74 billion in the year ended Dec 31, 2023 (+14.0%), $6.79 billion in the year ended Dec 31, 2022 (-1.6%) and $6.91 billion in the year ended Dec 31, 2021 (+12.2%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Research & Development since the quarter ended Mar 31, 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 322,296.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 4.25 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 4.65 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 2.57 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 4.54 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 3.02 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.65 Bn |
| Dec 31, 2025 | 10.01 Bn |
| Dec 31, 2024 | 8.22 Bn |
| Mar 31, 2024 | 1.82 Bn |
| Dec 31, 2023 | 7.72 Bn |
| Mar 31, 2023 | 1.53 Bn |
| Dec 31, 2022 | 6.44 Bn |
| Sep 30, 2022 | 1.59 Bn |
| Jun 30, 2022 | 1.56 Bn |
| Mar 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 6.77 Bn |
| Dec 31, 2020 | 1.94 Bn |
| Dec 31, 2019 | 1.60 Bn |
| Sep 30, 2019 | 1.49 Bn |
| Dec 31, 2018 | 1.38 Bn |
| Jun 30, 2018 | 1.26 Bn |
| Dec 31, 2017 | 1.61 Bn |
| Jun 30, 2017 | 1.61 Bn |
| Dec 31, 2016 | 1.25 Bn |
| Sep 30, 2016 | 1.21 Bn |
Gsk Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();